Galactomannan detection in computerized tomography‐based broncho‐alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis
- 28 April 2003
- journal article
- clinical trial
- Published by Wiley in British Journal of Haematology
- Vol. 121 (3) , 448-457
Abstract
Summary. We determined the value of galactomannan (GM) detection in computerized tomography (CT)‐based broncho‐alveolar lavage (BAL) fluid and serum for the diagnosis of invasive pulmonary aspergillosis (IPA) in haemato‐oncological patients with neutropenia. CT of the thorax and BAL were performed systematically at predefined clinical indications. GM was determined by sandwich enzyme‐linked immunosorbent assay; the clinicians were unaware of the results. Of 160 patients, 17 patients (10·6%) presented with proven, probable or suspected IPA. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of GM detection in CT‐based BAL fluid were all 100%. For GM detection in serially sampled serum, the sensitivity was 47%, the specificity 93%, the PPV 73% and the NPV 82%. A non‐blinded follow‐up study was performed to validate these results. In this study, 22 of 198 patients (11·1%) presented with IPA, and the sensitivity, specificity, PPV and NPV of GM detection in CT‐based BAL fluid were 85%, 100%, 100% and 88% respectively. None of BAL fluids obtained after antifungal treatment of 3 d or more were positive. These results indicate that, when CT is used systematically and at an early stage, GM detection in CT‐based BAL fluid has a high PPV for diagnosing IPA early in untreated patients.Keywords
This publication has 32 references indexed in Scilit:
- AspergillusGalactomannan Detection in the Diagnosis of Invasive Aspergillosis in Cancer PatientsJournal of Clinical Oncology, 2002
- Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International ConsensusClinical Infectious Diseases, 2002
- Detection of Aspergillus Species DNA by PCR in Bronchoalveolar Lavage FluidJournal of Clinical Microbiology, 2001
- Aspergillosis Case-Fatality Rate: Systematic Review of the LiteratureClinical Infectious Diseases, 2001
- Aspergillus antigen testing in bone marrow transplant recipientsJournal of Clinical Pathology, 2000
- Aspergillus Antigen in Serum, Urine and Bronchoalveolar Lavage Specimens of Neutropenic Patients in Relation to Clinical OutcomeScandinavian Journal of Infectious Diseases, 2000
- Therapeutic Outcome in Invasive AspergillosisClinical Infectious Diseases, 1996
- Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosisThe Pediatric Infectious Disease Journal, 1996
- Aspergillus antigenuria compared to antigenemia in bone marrow transplant recipientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994
- Galactomannan Antigenemia and Antigenuria in Aspergillosis: Studies in Patients and Experimentally Infected RabbitsThe Journal of Infectious Diseases, 1987